ConductScience.org, home

Paper30833190

OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling.

Song F and 6 others. EBioMedicine, 2019. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling. Papers, record 30833190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30833190

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling.
PubMed
Journal
EBioMedicine
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2020-02-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Song FFeifei
2Chen QQi
3Rao WWei
4Zhang RRenfeng
5Wang YYing
6Ge HHailiang
7Wei QQing

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Autocrine CommunicationMajor topic
Neovascularization, PathologicMajor topic
Ovarian NeoplasmsMajor topic
Vascular Endothelial Growth Factor AMajor topic
Vascular Endothelial Growth Factor Receptor-2Major topic
Animals
Antigens, Neoplasm
Female
HeLa Cells
Humans
Mice
Signal Transduction

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111416219CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11416219PubMed
218534745RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells.Cancer Lett2008https://conductscience.org/library/papers/18534745PubMed
318754882Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity.Cancer Sci2008https://conductscience.org/library/papers/18754882PubMed
419004006Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis.Int J Cancer2009https://conductscience.org/library/papers/19004006PubMed
520141840Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development.Cell2010https://conductscience.org/library/papers/20141840PubMed
620606083Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer.J Clin Oncol2010https://conductscience.org/library/papers/20606083PubMed
722101807Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Cancer Metastasis Rev2012https://conductscience.org/library/papers/22101807PubMed
822182449Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT.Cancer Lett2012https://conductscience.org/library/papers/22182449PubMed
922393126Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.J Exp Med2012https://conductscience.org/library/papers/22393126PubMed
1022693250VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.Cancer Res2012https://conductscience.org/library/papers/22693250PubMed
1123257828Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.Cell Adh Migr2012https://conductscience.org/library/papers/23257828PubMed
1223454747Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.J Clin Invest2013https://conductscience.org/library/papers/23454747PubMed
1324120473Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway.Gastroenterology2014https://conductscience.org/library/papers/24120473PubMed
1424263190VEGF targets the tumour cell.Nat Rev Cancer2013https://conductscience.org/library/papers/24263190PubMed
1524633332OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.PLoS One2014https://conductscience.org/library/papers/24633332PubMed
1624667688OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.Carcinogenesis2014https://conductscience.org/library/papers/24667688PubMed
1724849467Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma.Hepatology2014https://conductscience.org/library/papers/24849467PubMed
1825889301Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.Mol Cancer2015https://conductscience.org/library/papers/25889301PubMed
1926115797Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.Lancet Oncol2015https://conductscience.org/library/papers/26115797PubMed
2027025186Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.Lancet2016https://conductscience.org/library/papers/27025186PubMed

See all 26 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42897126Cytokine context shapes antigen-presenting and matrix-producing states of cancer-associated fibroblasts.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42897126PubMed
42190107Systemic cancer risk profile in neovascular age-related macular degeneration: insights into shared aging-related mechanisms from a nationwide population-based study.Aging (Albany NY)2026https://conductscience.org/library/papers/42190107PubMed
41331117β-Lapachone sensitizes glioblastoma to Temozolomide by inhibiting NF-κB signaling.Funct Integr Genomics2025https://conductscience.org/library/papers/41331117PubMed
39802400Valosin-containing protein (VCP), a component of tumor-derived extracellular vesicles, impairs the barrier integrity of brain microvascular endothelial cells.BBA Adv2025https://conductscience.org/library/papers/39802400PubMed
37338527Identifying the role of NUDCD1 in human tumors from clinical and molecular mechanisms: a study based on comprehensive bioinformatics and experimental validation.Aging (Albany NY)2023https://conductscience.org/library/papers/37338527PubMed
36835224Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study.Int J Mol Sci2023https://conductscience.org/library/papers/36835224PubMed
36402931Mast cells inhibit colorectal cancer development by inducing ER stress through secreting Cystatin C.Oncogene2023https://conductscience.org/library/papers/36402931PubMed
36361682Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings.Int J Mol Sci2022https://conductscience.org/library/papers/36361682PubMed
36358584Ishophloroglucin A Ameliorates VEGF-Induced Epithelial-Mesenchymal Transition via VEGFR2 Pathway Inhibition in Microgravity-Stimulated Human Retinal Pigment Epithelial Cells.Antioxidants (Basel)2022https://conductscience.org/library/papers/36358584PubMed
35476233
miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification.
J Cancer Res Clin Oncol2022https://conductscience.org/library/papers/35476233PubMed
34975330Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling.Int J Biol Sci2022https://conductscience.org/library/papers/34975330PubMed
34867402Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer.Front Pharmacol2021https://conductscience.org/library/papers/34867402PubMed
34325402NUDCD1 knockdown inhibits the proliferation, migration, and invasion of pancreatic cancer via the EMT process.Aging (Albany NY)2021https://conductscience.org/library/papers/34325402PubMed
34217063Nox2 impairs VEGF-A-induced angiogenesis in placenta via mitochondrial ROS-STAT3 pathway.Redox Biol2021https://conductscience.org/library/papers/34217063PubMed
34135585Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis.Int J Nanomedicine2021https://conductscience.org/library/papers/34135585PubMed
34050127Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis.Cell Death Dis2021https://conductscience.org/library/papers/34050127PubMed
33673178Angiotensin II and Angiotensin Receptors 1 and 2-Multifunctional System in Cells Biology, What Do We Know?Cells2021https://conductscience.org/library/papers/33673178PubMed
33193893VEGF promotes migration and invasion by regulating EMT and MMPs in nasopharyngeal carcinoma.J Cancer2020https://conductscience.org/library/papers/33193893PubMed
31777993RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.Cancer Sci2020https://conductscience.org/library/papers/31777993PubMed

Download CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FLT12321PubTator's text mininghttps://conductscience.org/library/genes/2321NCBI Gene
HSPG23339PubTator's text mininghttps://conductscience.org/library/genes/3339NCBI Gene
IGF1R3480PubTator's text mininghttps://conductscience.org/library/genes/3480NCBI Gene
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MAPK141432PubTator's text mininghttps://conductscience.org/library/genes/1432NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
NRP18829PubTator's text mininghttps://conductscience.org/library/genes/8829NCBI Gene
NUDCD184955PubTator's text mininghttps://conductscience.org/library/genes/84955NCBI Gene
PECAM15175PubTator's text mininghttps://conductscience.org/library/genes/5175NCBI Gene
PIK3CD5293PubTator's text mininghttps://conductscience.org/library/genes/5293NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
PTK25747PubTator's text mininghttps://conductscience.org/library/genes/5747NCBI Gene
RET5979PubTator's text mininghttps://conductscience.org/library/genes/5979NCBI Gene
SRC6714PubTator's text mininghttps://conductscience.org/library/genes/6714NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30833190

GET https://conductscience.org/api/papers/v1/30833190/references?page=2